ブロモエタン

Excerpt from ERG Guide 131 [Flammable Liquids - Toxic]:

Use water spray, powder, foam, carbon dioxide.

Fresh air, rest. Refer for medical attention.

Remove contaminated clothes. Rinse and then wash skin with water and soap. Refer for medical attention .

First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.

Refer for medical attention .

· CALL 911. Then call emergency response telephone number on shipping paper. If shipping paper not available or no answer, refer to appropriate telephone number listed on the inside back cover.

· ELIMINATE all ignition sources (no smoking, flares, sparks or flames) from immediate area.

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

General First Aid:

(General first aid procedures)

Suitable extinguishing media: Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

Advice for firefighters: Wear self-contained breathing apparatus for firefighting if necessary.

Use water spray to cool unopened containers.

If material on fire or involved in fire: Do not extinguish fire unless flow can be stopped. Use water in flooding quantities as fog. Solid streams of water may be ineffective. Cool all affected containers with flooding quantities of water. Use "alcohol" foam, dry chemical or carbon dioxide. Keep run-off water out of sewers and water sources.

Keep container tightly closed in a dry and well-ventilated place. Containers which are opened must be carefully resealed and kept upright to prevent leakage. Light sensitive. Refrigerate before opening. Over time, pressure may increase causing containers to burst. Handle and open container with care.

ACCIDENTAL RELEASE MEASURES: Personal precautions, protective equipment and emergency procedures: Use personal protective equipment. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Remove all sources of ignition. Evacuate personnel to safe areas. Beware of vapors accumulating to form explosive concentrations. Vapors can accumulate in low areas. Environmental precautions: Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. Methods and materials for containment and cleaning up: Contain spillage, and then collect with an electrically protected vacuum cleaner or by wet-brushing and place in container for disposal according to local regulations.

SRP: Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in air, soil or water; effects on animal, aquatic and plant life; and conformance with environmental and public health regulations. If it is possible or reasonable use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination.

SRP: Wastewater from contaminant suppression, cleaning of protective clothing/equipment, or contaminated sites should be contained and evaluated for subject chemical or decomposition product concentrations. Concentrations shall be lower than applicable environmental discharge or disposal criteria. Alternatively, pretreatment and/or discharge to a permitted wastewater treatment facility is acceptable only after review by the governing authority and assurance that "pass through" violations will not occur. Due consideration shall be given to remediation worker exposure (inhalation, dermal and ingestion) as well as fate during treatment, transfer and disposal. If it is not practicable to manage the chemical in this fashion, it must be evaluated in accordance with EPA 40 CFR Part 261, specifically Subpart B, in order to determine the appropriate local, state and federal requirements for disposal.

Product: Burn in a chemical incinerator equipped with an afterburner and scrubber but exert extra care in igniting as this material is highly flammable. Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste disposal service to dispose of this material; Contaminated packaging: Dispose of as unused product.

Evacuate danger area! Consult an expert! Remove all ignition sources. Ventilation. Collect leaking and spilled liquid in sealable metal containers as far as possible. Absorb remaining liquid in sand or inert absorbent. Then store and dispose of according to local regulations. Personal protection: chemical protection suit including self-contained breathing apparatus.

Clinical cases of occupational ethyl bromide intoxication observed between 1937 and 1942 /were reviewed/. ...Blood bromine concentration of patients suffering from ethyl bromide poisoning at the time of admission were reported to be 15-53 mg/100 mL. Spinal fluid bromine concentrations were 4-7 mg/100 mL. After 5-10 days without exposure, the patients' blood bromine levels were 5-7 mg/100 mL; however after 2-3 weeks, these returned to background levels of 0.61-1.81 mg/100 mL. No background levels for spinal fluid bromine concentration are reported. ...

EYES: irrigate opened eyes for several minutes under running water. INGESTION: do not induce vomiting. Rinse mouth with water (never give anything by mouth to an unconscious person). Seek immediate medical advice. SKIN: should be treated immediately by rinsing the affected parts in cold running water for at least 15 minutes, followed by thorough washing with soap and water. If necessary, the person should shower and change contaminated clothing and shoes, and then must seek medical attention. INHALATION: supply fresh air. If required provide artificial respiration.

There is a possible interaction of epinephrine with ethyl bromide. In studies with dogs, ethyl bromide and other halogenated compounds have been shown to cause cardiac syncope. Anesthetized dogs that had inhaled ethyl bromide and that were subsequently injected with 0.03 mg/kg epinephrine died of ventricular fibrillation.

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 22(SRC), determined from a structure estimation method(2), indicates that ethyl bromide is expected to have very high mobility in soil(SRC). Volatilization of ethyl bromide from moist soil surfaces is expected to be an important fate process(SRC) given an estimated Henry's Law constant of 7.4X10-3 atm-cu m/mole(SRC) based upon its vapor pressure, 467 mm Hg(3), and water solubility, 9,000 mg/L(4). Hydrolysis in moist soil may be an important environmental fate process(SRC) based upon aqueous hydrolysis half-lives of 40 and 30 days at pH 7 and at 20 and 25 °C, respectively(5,6). Ethyl bromide is expected to volatilize from dry soil surfaces(SRC) based upon its vapor pressure(3). Utilizing the Japanese MITI test, 33% of the Theoretical BOD was reached in 4 weeks(7) indicating that biodegradation is not likely to be a fast environmental fate process in soil(SRC).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 22(SRC), determined from a structure estimation method(2), indicates that ethyl bromide is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is expected(3) based upon an estimated Henry's Law constant of 7.4X10-3 atm-cu m/mole(SRC), derived from its vapor pressure, 467 mm Hg(4), and water solubility, 9,000 mg/L(5). Using this Henry's Law constant and an estimation method(3), volatilization half-lives for a model river and model lake are 3 hrs and 4 days, respectively(SRC). According to a classification scheme(6), an estimated BCF of 5(SRC), from its log Kow of 1.61(7) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Hydrolysis half-lives of 40 and 30 days at pH 7 and at 20 and 25 °C(8,9), respectively, indicate that hydrolysis is an important enviornmental fate process in water(SRC). Utilizing the Japanese MITI test, 33% of the Theoretical BOD was reached in 4 weeks(10) indicating that biodegradation is not likely to be a fast environmental fate process in water(SRC).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), ethyl bromide, which has a vapor pressure of 467 mm Hg at 25 °C(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase ethyl bromide is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 45 days(SRC), calculated from its rate constant of 3.5X10-13 cu cm/molecule-sec at 25 °C(3). Ethyl bromide does not contains chromophores that absorb at wavelengths >290 nm(4) and, therefore, is not expected to be susceptible to direct photolysis by sunlight(SRC).

The substance can be absorbed into the body by inhalation and by ingestion.

inhalation, ingestion, skin and/or eye contact

Oral (L626) ; inhalation (L626) ; dermal (L626)

IDENTIFICATION AND USE: Ethyl bromide is a colorless liquid with a vapor heavier than air. Ethyl bromide is used as an ethylating agent in chemical synthesis. Ethyl bromide was formerly used as a narcotic agent for dental and medical surgery. HUMAN STUDIES: The main health concerns relating to the exposure of ethyl bromide are the potential for neurotoxicity, irritation of the respiratory tract, damage to genetic material, carcinogenicity, hematotoxicity and hepatotoxicity. Limited human experience during surgical anesthesia has indicated that, in addition to CNS depression, there is a possibility of lung congestion and degeneration of the liver and kidney tissues. Symptoms of exposure to ethyl bromide include irritation of the skin, eyes, mucous membranes, and upper respiratory tract. Other symptoms include CNS depression, lung irritation, acute congestion and edema, liver damage, and kidney damage. It can cause nausea, dizziness, headache, and nervous system disturbances. Central nervous system depression, cardiac arrhythmias, and cardiac arrest may occur. Loss of balance, slurred speech, unconsciousness, and death can occur. Ingestion can cause burning of the digestive tract, vomiting, and moderate gastrointestinal upset. Skin rash may occur. It can affect motor control after repeated exposures. Heart damage has been reported. The course of ethyl bromide poisoning was described in three stages. The first stage lasted 2-4 days and involved a garlicky odor on the breath, sleepiness, fatigue, sharp pain and paresthesia of the lower legs, and staggering gate. During the second phase that lasted 2-5 days, the symptoms of the first phase grew more severe. The third phase was characterized by spastic paresthesia of the legs, disturbance of the peripheral nervous system, and atrophy of the lower leg. CNS disturbances can also occur at high ethyl bromide exposures. Prognosis for recovery is good for most patients. ANIMAL STUDIES: Immediate effects of ethyl bromide exposure in mice and rats included increased respiration, hyperactivity, incoordination, dyspnea, and coma. The liquid is apparently irritating to skin and eyes of rabbits and is reported to be absorbed through the skin. Exposure of rats and rabbits by inhalation at 538 ppm ethyl bromide for 4 hr/day for 6 months resulted in disruption of hepatic function as shown by a decrease in hepatic glycogen and fat levels as well as prolonged hexobarbital sleep. Hepatic cell granular dystrophy and decreased cytoplasmic RNA levels were also reported. Another study reported that exposure of rats, also at 538 ppm of ethyl bromide by inhalation resulted in hyperplasia and hypertrophy of the pituitary gland, hypertrophy of the cortex, and increased lipid content of the adrenal gland. Severe testicular atrophy was observed in rats, but not in mice, at 1600 ppm (7.14 g/cu m) ethyl bromide but not at lower concentrations. ln female mice, but not in rats, the size and number of corpora lutea in the ovary were decreased at 1600 ppm (7/10 animals) and at 800 ppm (3.57 g/cu m, 3/9 animals). Ethyl bromide was mutagenic to bacteria, but not to Drosophila melanogaster in a single study. In another single study, ethyl bromide increased the incidence of sister chromatid exchanges, but not of chromosomal aberrations in cultured mammalian cells. In a two year carcinogenicity bioassay by inhalation, a dose related increase in uterine tumors was observed in female mice. A small increase in the incidence of gliomas was found in female rats exposed to the highest dose used.

The release of ethyl bromide by polar macroalgae (Phaeophyta (brown), Rhodophyta (red) and Chlorophyta (green) species native to King George Island, Antarctic; green species native to Spitsbergen and Disko Island, Greenland) was investigated at 0 °C under a laboratory setting(1).[Table#1523]

Drowsiness. Unconsciousness.

Pain. Redness.

irritation eyes, skin, respiratory system; central nervous system depression; pulmonary edema; liver, kidney disease; cardiac arrhythmias, cardiac arrest

Inhalation can cause drowsiness and excessive amounts can lead to unconsciousness. Exposure to eyes can lead to redness and pain.

The following link will take the user to the National Toxicology Program (NTP) Test Status of Agents Search page, which tabulates the results and current status of tests such as "Short-Term Toxicity Studies", "Long-term Carcinogenicity Studies", "Developmental Studies", "Genetic Toxicology Studies", etc., performed with this chemical. Testing status for ethyl bromide is available.[Available from, as of February 1, 2019: https://ntpsearch.niehs.nih.gov/?e=True&ContentType=Testing+Status]

EPA has released the Interactive Chemical Safety for Sustainability (iCSS) Dashboard. The iCSS Dashboard provides an interactive tool to explore rapid, automated (or in vitro high-throughput) chemical screening data generated by the Toxicity Forecaster (ToxCast) project and the federal Toxicity Testing in the 21st century (Tox21) collaboration. /The title compound was tested by ToxCast and/or Tox21 assays/[USEPA; ICSS Dashboard Application; Available from, as of February 4, 2019: http://actor.epa.gov/dashboard/]

Section 8(a) of TSCA requires manufacturers of this chemical substance to report preliminary assessment information concerned with production, exposure, and use to EPA as cited in the preamble in 51 FR 41329. Effective date: 3/11/94; Reporting date: 5/10/94.

Pursuant to section 8(d) of TSCA, EPA promulgated a model Health and Safety Data Reporting Rule. The section 8(d) model rule requires manufacturers, importers, and processors of listed chemical substances and mixtures to submit to EPA copies and lists of unpublished health and safety studies. Ethyl bromide is included on this list. Effective date: 3/11/94; Sunset date: 6/30/98.

This action promulgates standards of performance for equipment leaks of Volatile Organic Compounds (VOC) in the Synthetic Organic Chemical Manufacturing Industry (SOCMI). The intended effect of these standards is to require all newly constructed, modified, and reconstructed SOCMI process units to use the best demonstrated system of continuous emission reduction for equipment leaks of VOC, considering costs, non air quality health and environmental impact and energy requirements. Ethyl bromide is produced, as an intermediate or a final product, by process units covered under this subpart.